Name: Latest research reports of J B Chemicals & Pharmaceuticals Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: J B Chemicals & Pharmaceuticals Ltd.
Rating: 4
Author: ICICI Securities Limited

J B Chemicals & Pharmaceuticals Ltd.

NSE: JBCHEPHARM | BSE: 506943 | ISIN: INE572A01036 | Industry: Pharmaceuticals
| Mid-range Performer

1801.4000 49.10 (2.80%)

NSE Jun 27, 2025 15:31 PM

29.99% Gain from 52W Low

Volume: 244.9K

J B Chemicals & Pharmaceuticals Ltd.

10 Feb 2023

1801.40

2.80%

In-line performance

Accumulate: J B Chemicals & Pharmaceut...

Target

ICICI Securities Limited

JB Chemicals & Pharmaceuticals (JBCPL) Q3FY23 performance was broadly in line with our estimates, driven by robust growth across the segments. Consolidated revenue grew 32% YoY to Rs7.9bn (I-Sec: 7.7bn) driven by acquisitions in India.

Number of FII/FPI investors increased from 294 to 319 in Mar 2025 qtr.

The Baseline | 27 Jun 2025, 05:49PM

Market closes higher, Ahluwalia bags Rs 1,103.6 crore residential projects in Gurugram and Bengaluru

Trendlyne Marketwatch | 27 Jun 2025, 03:57PM

New leadership, fresh strategy at JB Chemicals sees impact in Q1FY23

| 09 Sep 2022